Where does Mybiotics Pharma Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mybiotics Pharma Ltd. ranks #36,582 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mybiotics Pharma Ltd. hold?

Mybiotics Pharma Ltd. holds 7 US utility patents granted between 2020 and 2025, spanning 4 technology areas.

What is Mybiotics Pharma Ltd.'s Innovation Score?

Mybiotics Pharma Ltd. has an Innovation Score of 27.4 out of 100 (24th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mybiotics Pharma Ltd. focus on?

Mybiotics Pharma Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 7 patents, ranking #3,032 of 7,163 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Mybiotics Pharma Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Mybiotics Pharma Ltd..

What does claim depth mean for Mybiotics Pharma Ltd.'s patents?

Mybiotics Pharma Ltd.'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mybiotics Pharma Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Mybiotics Pharma Ltd.

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mybiotics ranks #36,582 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#36,582
of 49,997 US assignees by volume: 24th percentile
by Innovation Score (27.4/100): 16.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R36582 · Foreign Corporation #36,582 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #36,582/49,997
PHOTO-FINISH Maana
CPC-NARROW A61K · 4 areas
INNOV-THIN 27.4/100
CLAIMS-RICH 16.4 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Maana, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mybiotics’s 27.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (26%) Velocity 3.3 pts (12%) Breadth 7.1 pts (26%) Claim depth 9.9 pts (36%)

Qualcomm Incorporated · highest

85
Mybiotics Pharma · this assignee

27
3D Lighting… · lowest

7

What this shows Mybiotics's Innovation Score is 27.4/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mybiotics?

Each dot is one of Mybiotics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mybiotics’s own 16.4 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mybiotics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mybiotics's grants concentrate

Mybiotics Pharma Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). By volume, Mybiotics sits between Multiverse Computing SL and Maastricht University.

Mybiotics's three-year grant acceleration

Mybiotics Pharma Ltd. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Multiverse Comput…

7
Munro Design &

7
Murrelektronik

7
Must Holding

7
Mycelebs

7
Mycelx

7
Maana

7
Maastricht Univer…

7
Mybiotics Pharma ◀

7

What this shows Mybiotics holds 7 patents at rank #36,435, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mybiotics

By rank, the assignees closest to #36,435 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Mybiotics's primary technology class.

Mybiotics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 24th percentile higher than 24% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Mybiotics Pharma Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	28.6%
2021	2	28.6%
2023	2	28.6%
2025partial year	1	14.3%

Which technologies does Mybiotics Pharma Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mybiotics Pharma Ltd.'s patent record in context - here's where to go next.

Mybiotics Pharma Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #36,582 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mybiotics Pharma Ltd. against Multiverse Computing SL, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.